Ionis Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
32.26
-0.49
(-1.5%)
Volume:
946,934
52 week range:
23.95 - 52.34
Market Cap:
5.134B
Company Description:
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy.